{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T05:01:39Z","timestamp":1785128499746,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"DOI":"10.1007\/s00417-026-07416-9","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T04:55:34Z","timestamp":1785128134000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Structural and microvascular retinal changes in tamoxifen users assessed by optical coherence tomography and OCT angiography"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7721-8727","authenticated-orcid":false,"given":"Songul","family":"Kilic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4544-1021","authenticated-orcid":false,"given":"Mine","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7173-8617","authenticated-orcid":false,"given":"Abdullah","family":"A\u011f\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3752-9181","authenticated-orcid":false,"given":"Feyza","family":"Onder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"issue":"9","key":"7416_CR1","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s004170050139","volume":"236","author":"F Lazzaroni","year":"1998","unstructured":"Lazzaroni F, Scorolli L, Pizzoleo CF, Savini G, De Nigris A, Giosa F et al (1998) Tamoxifen retinopathy: does it really exist? Graefes Arch Clin Exp Ophthalmol 236(9):669\u2013673. https:\/\/doi.org\/10.1007\/s004170050139","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7416_CR2","doi-asserted-by":"publisher","unstructured":"Doshi RR, Fortun JA, Kim BT, Dubovy SR, Rosenfeld PJ (2014) Pseudocystic foveal cavitation in tamoxifen retinopathy. Am J Ophthalmol. ;157(6):1291-8 e3. https:\/\/doi.org\/10.1016\/j.ajo.2014.02.046","DOI":"10.1016\/j.ajo.2014.02.046"},{"issue":"3","key":"7416_CR3","doi-asserted-by":"publisher","first-page":"313","DOI":"10.4103\/0973-1482.73332","volume":"6","author":"N Srikantia","year":"2010","unstructured":"Srikantia N, Mukesh S, Krishnaswamy M (2010) Crystalline maculopathy: a rare complication of tamoxifen therapy. J Cancer Res Ther 6(3):313\u2013315. https:\/\/doi.org\/10.4103\/0973-1482.73332","journal-title":"J Cancer Res Ther"},{"issue":"10","key":"7416_CR4","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3928\/23258160-20170928-10","volume":"48","author":"MG Ersoz","year":"2017","unstructured":"Ersoz MG, Arf S, Karacorlu M, Hocaoglu M, Muslubas IS (2017) Pachychoroid Pigment Epitheliopathy Associated With Tamoxifen. Ophthalmic Surg Lasers Imaging Retina 48(10):838\u2013842. https:\/\/doi.org\/10.3928\/23258160-20170928-10","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"12","key":"7416_CR5","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1002\/1097-0142(19920615)69:12<2961::aid-cncr2820691215>3.0.co;2-w","volume":"69","author":"NA Pavlidis","year":"1992","unstructured":"Pavlidis NA, Petris C, Briassoulis E, Klouvas G, Psilas C, Rempapis J et al (1992) Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity. A prospective study of 63 patients. Cancer 69(12):2961\u20132964. https:\/\/doi.org\/10.1002\/1097-0142(19920615)69:12%3C2961::aid-cncr2820691215%3E3.0.co;2-w","journal-title":"Cancer"},{"issue":"Pt 6","key":"7416_CR6","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/eye.1999.217","volume":"13","author":"BN Noureddin","year":"1999","unstructured":"Noureddin BN, Seoud M, Bashshur Z, Salem Z, Shamseddin A, Khalil A (1999) Ocular toxicity in low-dose tamoxifen: a prospective study. Eye (Lond) 13(Pt 6):729\u2013733. https:\/\/doi.org\/10.1038\/eye.1999.217","journal-title":"Eye (Lond)"},{"issue":"8","key":"7416_CR7","doi-asserted-by":"publisher","first-page":"4747","DOI":"10.1167\/iovs.13-13662","volume":"55","author":"LA Kim","year":"2014","unstructured":"Kim LA, Amarnani D, Gnanaguru G, Tseng WA, Vavvas DG, D\u2019Amore PA (2014) Tamoxifen toxicity in cultured retinal pigment epithelial cells is mediated by concurrent regulated cell death mechanisms. Invest Ophthalmol Vis Sci 55(8):4747\u20134758. https:\/\/doi.org\/10.1167\/iovs.13-13662","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"7416_CR8","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.oftal.2020.05.028","volume":"95","author":"ML Martinez","year":"2020","unstructured":"Martinez ML, Bastien A, Giambruni JM, Bursztyn M, Ravazzola MN, Challiol CF (2020) Tamoxifen retinal toxicity. Monitoring by multimodal imaging study. Arch Soc Esp Oftalmol (Engl Ed) 95(10):496\u2013500. https:\/\/doi.org\/10.1016\/j.oftal.2020.05.028","journal-title":"Arch Soc Esp Oftalmol (Engl Ed)"},{"issue":"9","key":"7416_CR9","first-page":"1906","volume":"40","author":"SB Ogueta","year":"1999","unstructured":"Ogueta SB, Schwartz SD, Yamashita CK, Farber DB (1999) Estrogen receptor in the human eye: influence of gender and age on gene expression. Invest Ophthalmol Vis Sci 40(9):1906\u20131911","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"7416_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1167\/iovs.66.12.19","volume":"66","author":"EE Oskan","year":"2025","unstructured":"Oskan EE, Agin A, Ozturk M, Onder F (2025) Evaluation of Reflectivities of RPE, ELM, EZ, and Their Relationship With Subretinal Fluid Properties in Central Serous Chorioretinopathy. Invest Ophthalmol Vis Sci 66(12):19. https:\/\/doi.org\/10.1167\/iovs.66.12.19","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"7416_CR11","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.1007\/s00417-024-06532-8","volume":"262","author":"A Yucel Gencoglu","year":"2024","unstructured":"Yucel Gencoglu A, Agin A, Colak D, Un Y, Ozturk Y (2024) Decreased peri-parafoveal RPE, EZ and ELM intensity: A novel predictive biomarker for hydroxychloroquine retinal toxicity. Graefes Arch Clin Exp Ophthalmol 262(11):3543\u20133552. https:\/\/doi.org\/10.1007\/s00417-024-06532-8","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"7416_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/15569527.2023.2220388","volume":"42","author":"IE Erbahceci Timur","year":"2023","unstructured":"Erbahceci Timur IE, Acikgoz V, Ugurlu N, Yalcin B, Sendur MAN, Hizal M et al (2023) Tamoxifen related chorioretinal structural changes. Cutan Ocul Toxicol 42(3):109\u2013117. https:\/\/doi.org\/10.1080\/15569527.2023.2220388","journal-title":"Cutan Ocul Toxicol"},{"issue":"2","key":"7416_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/15569527.2020.1734816","volume":"39","author":"S Bolukbasi","year":"2020","unstructured":"Bolukbasi S, Kandemir Gursel O, Cakir A, Erden B, Karatas G (2020) Retinal structural changes in patients receiving tamoxifen therapy by spectral-domain optical coherence tomography. Cutan Ocul Toxicol 39(2):115\u2013121. https:\/\/doi.org\/10.1080\/15569527.2020.1734816","journal-title":"Cutan Ocul Toxicol"},{"issue":"6","key":"7416_CR14","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1097\/IAE.0000000000002533","volume":"40","author":"S Crisostomo","year":"2020","unstructured":"Crisostomo S, Vieira L, Cardigos J, Fernandes DH, Luis ME, Nunes S et al (2020) TAMOXIFEN-INDUCED CHORIORETINAL CHANGES: An Optical Coherence Tomography and Optical Coherence Tomography Angiography Study. Retina 40(6):1185\u20131190. https:\/\/doi.org\/10.1097\/IAE.0000000000002533","journal-title":"Retina"},{"issue":"5","key":"7416_CR15","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.oret.2017.01.001","volume":"1","author":"B Todorich","year":"2017","unstructured":"Todorich B, Yonekawa Y, Thanos A, Randhawa S (2017) OCT Angiography Findings in Tamoxifen Maculopathy. Ophthalmol Retina 1(5):450\u2013452. https:\/\/doi.org\/10.1016\/j.oret.2017.01.001","journal-title":"Ophthalmol Retina"},{"issue":"1","key":"7416_CR16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10549-006-9187-y","volume":"99","author":"M Mauget-Faysse","year":"2006","unstructured":"Mauget-Faysse M, Gambrelle J, Quaranta-El Maftouhi M (2006) Optical coherence tomography in tamoxifen retinopathy. Breast Cancer Res Treat 99(1):117\u2013118. https:\/\/doi.org\/10.1007\/s10549-006-9187-y","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"7416_CR17","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jfo.2019.12.004","volume":"43","author":"F Zamorano Martin","year":"2020","unstructured":"Zamorano Martin F, Rocha-de-Lossada C, Rachwani Anil R, Borroni D, Rodriguez Calvo de Mora M, Espana Contreras M (2020) Tamoxifen maculopathy: The importance of screening and long follow-up. J Fr Ophtalmol 43(8):727\u2013730. https:\/\/doi.org\/10.1016\/j.jfo.2019.12.004","journal-title":"J Fr Ophtalmol"},{"issue":"9","key":"7416_CR18","doi-asserted-by":"publisher","first-page":"5344","DOI":"10.1167\/iovs.12-9827","volume":"53","author":"KS Cho","year":"2012","unstructured":"Cho KS, Yoon YH, Choi JA, Lee SJ, Koh JY (2012) Induction of autophagy and cell death by tamoxifen in cultured retinal pigment epithelial and photoreceptor cells. Invest Ophthalmol Vis Sci 53(9):5344\u20135353. https:\/\/doi.org\/10.1167\/iovs.12-9827","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"7416_CR19","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/78774","volume":"3","author":"MA Dyer","year":"2000","unstructured":"Dyer MA, Cepko CL (2000) Control of Muller glial cell proliferation and activation following retinal injury. Nat Neurosci 3(9):873\u2013880. https:\/\/doi.org\/10.1038\/78774","journal-title":"Nat Neurosci"},{"issue":"1","key":"7416_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/s0161-6420(81)35071-4","volume":"88","author":"MI Kaiser-Kupfer","year":"1981","unstructured":"Kaiser-Kupfer MI, Kupfer C, Rodrigues MM (1981) Tamoxifen retinopathy. A clinicopathologic report. Ophthalmology 88(1):89\u201393. https:\/\/doi.org\/10.1016\/s0161-6420(81)35071-4","journal-title":"Ophthalmology"},{"issue":"14","key":"7416_CR21","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1167\/iovs.65.14.36","volume":"65","author":"L Goerdt","year":"2024","unstructured":"Goerdt L, Rodriguez Garcia JL, Kunzel SH, Pfau K, Raming K, Tzaridis S et al (2024) Prognostic Relevance of Relative Ellipsoid Zone Reflectivity for Ellipsoid Zone Loss in Macular Telangiectasia Type 2. Invest Ophthalmol Vis Sci 65(14):36. https:\/\/doi.org\/10.1167\/iovs.65.14.36","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"7416_CR22","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.survophthal.2023.07.003","volume":"69","author":"S Tenney","year":"2024","unstructured":"Tenney S, Oboh-Weilke A, Wagner D, Chen MY (2024) Tamoxifen retinopathy: A comprehensive review. Surv Ophthalmol 69(1):42\u201350. https:\/\/doi.org\/10.1016\/j.survophthal.2023.07.003","journal-title":"Surv Ophthalmol"},{"issue":"Pt 3","key":"7416_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/eye.1997.64","volume":"11","author":"R Tang","year":"1997","unstructured":"Tang R, Shields J, Schiffman J, Li H, Locher D, Hampton J et al (1997) Retinal changes associated with tamoxifen treatment for breast cancer. Eye (Lond) 11(Pt 3):295\u2013297. https:\/\/doi.org\/10.1038\/eye.1997.64","journal-title":"Eye (Lond)"},{"issue":"4","key":"7416_CR24","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.ophtha.2019.10.038","volume":"127","author":"HA Kim","year":"2020","unstructured":"Kim HA, Lee S, Eah KS, Yoon YH (2020) Prevalence and Risk Factors of Tamoxifen Retinopathy. Ophthalmology 127(4):555\u2013557. https:\/\/doi.org\/10.1016\/j.ophtha.2019.10.038","journal-title":"Ophthalmology"},{"issue":"1","key":"7416_CR25","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1186\/s12886-025-03971-7","volume":"25","author":"MR Abdol Homayuni","year":"2025","unstructured":"Abdol Homayuni MR, Sadeghi R, Poshtdar S, Ramandi A, Nikfar R, Ebrahimiadib N (2025) Optical coherence tomography angiography measurements in tamoxifen associated retinopathy: a systematic review and meta-analysis. BMC Ophthalmol 25(1):373. https:\/\/doi.org\/10.1186\/s12886-025-03971-7","journal-title":"BMC Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07416-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-026-07416-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07416-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T04:55:35Z","timestamp":1785128135000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-026-07416-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":25,"alternative-id":["7416"],"URL":"https:\/\/doi.org\/10.1007\/s00417-026-07416-9","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"12 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study adhered to the principles outlined in the Declaration of Helsinki, and written informed consent was obtained from all participants.","order":1,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}]}}